2nd Circ. Shoots Down Zyprexa MDL Atty's Fee Appeal

Law360, New York (February 3, 2010, 4:05 PM EST) -- A federal appeals court has dismissed a challenge by attorney Patrick Mulligan, who represents more than 2,000 plaintiffs in multidistrict litigation over Eli Lilly & Co.'s antipsychotic Zyprexa, to orders capping attorneys' fees and requiring some settlement money to be set aside for a common benefit fund.

A three-judge panel of the U.S. Court of Appeals for the Second Circuit ruled per curiam on Wednesday that it didn't have jurisdiction over Mulligan's appeal of the district court orders because it didn't relate to any the underlying...
To view the full article, register now.